Legend Biotech (LEGN) Other Accumulated Expenses (2019 - 2025)

Legend Biotech's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• Quarterly Other Accumulated Expenses rose 100.0% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 100.0% YoY) and the FY2025 annual result came in at $1.0 million, up 100.0% from the prior year.
• Other Accumulated Expenses was $1.0 million for Q4 2025 at Legend Biotech, roughly flat from $1.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $184.1 million in Q4 2022 and bottomed at $80096.0 in Q1 2021.
• A 5-year average of $99.9 million and a median of $122.9 million in 2021 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses jumped 128705.84% — and 2024, when it tumbled 99.59%.
• Legend Biotech's Other Accumulated Expenses stood at $123.6 million in 2021, then jumped by 49.01% to $184.1 million in 2022, then slumped by 33.57% to $122.3 million in 2023, then tumbled by 99.59% to $500000.0 in 2024, then jumped by 100.0% to $1.0 million in 2025.
• Business Quant data shows LEGN's Other Accumulated Expenses at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $138.8 million in Q2 2025.